{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-013896","form_type":"8-K","ticker":"XFOR","cik":"0001501697","company_name":"X4 Pharmaceuticals, Inc","filed_at":"2024-04-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.699468+00:00","generated_at":"2026-06-04T04:32:35.758234+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"X4 Pharmaceuticals posts updated corporate presentation on website","bullets":["X4 Pharmaceuticals filed an 8-K on April 1, 2024, announcing an updated corporate presentation.","The presentation is available on the Investors section of the company's website at www.x4pharma.com.","No financial results, material agreements, or other major events were disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-013896","json":"https://secwatch.observer/filing/0001628280-24-013896.json","markdown":"https://secwatch.observer/filing/0001628280-24-013896.md","text":"https://secwatch.observer/filing/0001628280-24-013896.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1501697/000162828024013896/0001628280-24-013896-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1501697/000162828024013896/xfor-20240401.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T04:32:35.758234+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}